Associated Papers
A new brain-penetrant glucosylceramide synthase inhibitor as potential Therapeutics for Gaucher disease.
Fujii T et al.
Journal of Neurochemistry, 2021
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3.
Wilson MW et al.
Acs Chemical Neuroscience, 2020
Select a paper to view details